PL3831385T3 - Sole migdalanowe enancjomerów pirlindolu do stosowania w medycynie - Google Patents
Sole migdalanowe enancjomerów pirlindolu do stosowania w medycynieInfo
- Publication number
- PL3831385T3 PL3831385T3 PL20198230.3T PL20198230T PL3831385T3 PL 3831385 T3 PL3831385 T3 PL 3831385T3 PL 20198230 T PL20198230 T PL 20198230T PL 3831385 T3 PL3831385 T3 PL 3831385T3
- Authority
- PL
- Poland
- Prior art keywords
- medicine
- mandelate salts
- pirlindole enantiomers
- pirlindole
- enantiomers
- Prior art date
Links
- IWVRVEIKCBFZNF-UHFFFAOYSA-N LSM-1636 Chemical class C1CNC2CCCC3=C2N1C1=CC=C(C)C=C13 IWVRVEIKCBFZNF-UHFFFAOYSA-N 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- IWYDHOAUDWTVEP-UHFFFAOYSA-M mandelate Chemical class [O-]C(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-M 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4995—Pyrazines or piperazines forming part of bridged ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/PT2014/000026 WO2015171002A1 (en) | 2014-05-09 | 2014-05-09 | Pharmaceutically acceptable salts of pirlindole enantiomers for use in medicine |
EP20198230.3A EP3831385B1 (en) | 2014-05-09 | 2014-05-09 | Mandelate salts of pirlindole enantiomers for use in medicine |
Publications (1)
Publication Number | Publication Date |
---|---|
PL3831385T3 true PL3831385T3 (pl) | 2024-10-14 |
Family
ID=50819928
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL20198230.3T PL3831385T3 (pl) | 2014-05-09 | 2014-05-09 | Sole migdalanowe enancjomerów pirlindolu do stosowania w medycynie |
Country Status (24)
Country | Link |
---|---|
US (1) | US10226460B2 (pl) |
EP (2) | EP3831385B1 (pl) |
JP (1) | JP6400121B2 (pl) |
KR (1) | KR102276281B1 (pl) |
CN (1) | CN106413713B (pl) |
AU (1) | AU2014393487B2 (pl) |
CA (1) | CA2948595C (pl) |
DK (1) | DK3831385T3 (pl) |
EC (1) | ECSP16086196A (pl) |
FI (1) | FI3831385T3 (pl) |
IL (1) | IL248852B (pl) |
LT (1) | LT3831385T (pl) |
MA (1) | MA39450B2 (pl) |
MX (1) | MX2016014704A (pl) |
NZ (1) | NZ726127A (pl) |
PH (1) | PH12016502235A1 (pl) |
PL (1) | PL3831385T3 (pl) |
PT (1) | PT3831385T (pl) |
RS (1) | RS65918B1 (pl) |
RU (1) | RU2706688C2 (pl) |
SA (1) | SA516380258B1 (pl) |
TN (1) | TN2016000495A1 (pl) |
UA (1) | UA118587C2 (pl) |
WO (1) | WO2015171002A1 (pl) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX368734B (es) * | 2014-05-09 | 2019-10-14 | Tecnimede Sociedade Tecnico Medicinal S | (s)-pirlindol o sus sales farmaceuticamente aceptables para uso en medicina. |
PT3054950T (pt) | 2014-05-09 | 2017-11-29 | Tecnimede-Sociedade Tecnico-Medicinal S A | (r)-pirlindol ou seus sais farmaceuticamente aceitáveis para uso em medicina |
EP3392250A1 (en) * | 2017-04-21 | 2018-10-24 | Tecnimede-Sociedade Tecnico-Medicinal, S.A. | Process for the preparation of piperazine ring for the synthesis of pyrazinocarbazole derivatives |
EP3392251A1 (en) * | 2017-04-21 | 2018-10-24 | Tecnimede-Sociedade Tecnico-Medicinal, S.A. | Process for the preparation of pirlindole enantiomers and its salts |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NO166131C (no) * | 1985-06-20 | 1991-06-05 | Daiichi Seiyaku Co | Analogifremgangsmaate for fremstilling av s(-)-pyridobenzoksazinforbindelser. |
EP1558231A4 (en) * | 2002-10-03 | 2010-09-08 | Cypress Bioscience Inc | DOSAGE CLIMBING AND FRICTIONAL DAILY DOSE OF ANTIDEPRESSANTS TO TREAT NEUROLOGICAL DISORDERS |
EP1688161A1 (en) * | 2004-11-02 | 2006-08-09 | Switch Biotech Aktiengesellschaft | Use of pirlindole for the treatment of diseases which are characterized by proliferation of t-lymphocytes and/or hyperproliferation of keratinocytes in particular atopic dermatitis and psoriasis |
BRPI0922871A2 (pt) * | 2008-12-11 | 2016-11-16 | Biovista Inc | metodos para o tratamento da esclerose múltipla usando pirazinoindóis tetracíclicos |
WO2014062621A1 (en) * | 2012-10-15 | 2014-04-24 | Stc.Unm | Treatment of autophagy-based disorders and related pharmaceutical compositions, diagnostic and screening assays and kits |
MX368734B (es) * | 2014-05-09 | 2019-10-14 | Tecnimede Sociedade Tecnico Medicinal S | (s)-pirlindol o sus sales farmaceuticamente aceptables para uso en medicina. |
PT3054950T (pt) * | 2014-05-09 | 2017-11-29 | Tecnimede-Sociedade Tecnico-Medicinal S A | (r)-pirlindol ou seus sais farmaceuticamente aceitáveis para uso em medicina |
EP3140265B1 (en) * | 2014-05-09 | 2019-08-28 | Tecnimede-Sociedade Tecnico-Medicinal, S.A. | Process for obtaining optically active pirlindole enantiomers and salts thereof |
-
2014
- 2014-05-09 PL PL20198230.3T patent/PL3831385T3/pl unknown
- 2014-05-09 AU AU2014393487A patent/AU2014393487B2/en active Active
- 2014-05-09 FI FIEP20198230.3T patent/FI3831385T3/fi active
- 2014-05-09 WO PCT/PT2014/000026 patent/WO2015171002A1/en active Application Filing
- 2014-05-09 EP EP20198230.3A patent/EP3831385B1/en active Active
- 2014-05-09 DK DK20198230.3T patent/DK3831385T3/da active
- 2014-05-09 RU RU2016148174A patent/RU2706688C2/ru active
- 2014-05-09 LT LTEP20198230.3T patent/LT3831385T/lt unknown
- 2014-05-09 TN TN2016000495A patent/TN2016000495A1/en unknown
- 2014-05-09 NZ NZ726127A patent/NZ726127A/en unknown
- 2014-05-09 RS RS20240989A patent/RS65918B1/sr unknown
- 2014-05-09 CA CA2948595A patent/CA2948595C/en active Active
- 2014-05-09 CN CN201480078725.0A patent/CN106413713B/zh active Active
- 2014-05-09 MX MX2016014704A patent/MX2016014704A/es active IP Right Grant
- 2014-05-09 PT PT201982303T patent/PT3831385T/pt unknown
- 2014-05-09 KR KR1020167031370A patent/KR102276281B1/ko active IP Right Grant
- 2014-05-09 US US15/309,981 patent/US10226460B2/en active Active
- 2014-05-09 JP JP2016567531A patent/JP6400121B2/ja active Active
- 2014-05-09 UA UAA201611335A patent/UA118587C2/uk unknown
- 2014-05-09 MA MA39450A patent/MA39450B2/fr unknown
- 2014-05-09 EP EP14726441.0A patent/EP3139926A1/en not_active Withdrawn
-
2016
- 2016-11-09 EC ECIEPI201686196A patent/ECSP16086196A/es unknown
- 2016-11-09 PH PH12016502235A patent/PH12016502235A1/en unknown
- 2016-11-09 SA SA516380258A patent/SA516380258B1/ar unknown
- 2016-11-09 IL IL248852A patent/IL248852B/en active IP Right Grant
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1231474A1 (zh) | 磷脂酰肌醇 -激酶抑制劑 | |
HK1231477A1 (zh) | 磷脂酰肌醇 -激酶抑制劑 | |
SI3125883T1 (sl) | Indol derivati za uporabo v medicini | |
IL252873A0 (en) | The l-tartrate salt of pridopidine | |
IL247072A0 (en) | Medical use | |
HK1231476A1 (zh) | 磷脂酰肌醇 -激酶抑制劑 | |
IL251988A0 (en) | Compounds acting on glycans and methods of using them | |
IL249079A0 (en) | Phosphatidylinositol 3-kinase inhibitors | |
IL248789A0 (en) | History of quinazolinones as phosphatidylinositol 3-kinase inhibitors | |
SG11201609540TA (en) | Phosphatidylinositol 3-kinase inhibitors | |
SI3089971T1 (sl) | Spojine in postopki za uporabo | |
ZA201606450B (en) | Compounds and their methods of use | |
IL248852A0 (en) | Pharmaceutically acceptable salts of pyrilindole enantiomers for use in medicine | |
ZA201607722B (en) | Process for obtaining optically active pirlindole enantiomers and salts thereof | |
GB201608510D0 (en) | Apparatus for clinical use | |
IL235340A (en) | One-time vase | |
GB201403697D0 (en) | Compounds and methods of use | |
TH1601006735A (th) | เกลือที่ยอมรับได้ทางเภสัชกรรมของเพอร์ลินโดลอีแนนทิโอเมอร์สำหรับ การใช้ในยารักษาโรค | |
GB201408594D0 (en) | New salts |